(Q42856597)

English

Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial

scientific article published on 16 October 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

0 references

0 references

chronic heart failure

1 reference

based on heuristic

inferred from title

Aldo P. Maggioni

11

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

object named as

Stefano Ghio

1

0 references

12

object named as

Luigi Tavazzi

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

author name string

Laura Scelsi

2

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Roberto Latini

3

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Serge Masson

4

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Ermanno Eleuteri

5

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Michela Palvarini

6

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Olga Vriz

7

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Michele Pasotti

8

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Marco Gorini

9

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Roberto Marchioli

10

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

GISSI-HF investigators

13

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

publication date

16 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

1345-1353

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ172

21 January 2018

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ172

21 January 2018

Omega-3 fatty acids and heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ172

21 January 2018

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ172

21 January 2018

Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ172

21 January 2018

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ172

21 January 2018

Fish intake and risk of incident heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ172

21 January 2018

Fish, omega-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women the JACC (Japan Collaborative Cohort Study for Evaluation of Cancer Risk) Study

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ172

21 January 2018

Plasma fatty acid composition and incident heart failure in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ172

21 January 2018

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ172

21 January 2018

Fish oil supplementation improves left ventricular function in children with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ172

21 January 2018

Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: results of the SENIORS echocardiographic substudy

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ172

21 January 2018

Dietary supplementation with omega-3 PUFA increases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overload

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ172

21 January 2018

Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ172

21 January 2018

Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ172

21 January 2018

Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile function.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ172

21 January 2018

Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ172

21 January 2018

Rosuvastatin in older patients with systolic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ172

21 January 2018

Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ172

21 January 2018

Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ172

21 January 2018

Pravastatin improves function in hibernating myocardium by mobilizing CD133+ and cKit+ bone marrow progenitor cells and promoting myocytes to reenter the growth phase of the cardiac cell cycle.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ172

21 January 2018

The cornucopia of "pleiotropic" actions of statins: myogenesis as a new mechanism for statin-induced benefits?

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ172

21 January 2018

Identifiers

10.1093/EURJHF/HFQ172

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42856597&oldid=1972773802"